Abcuro, Inc. logo

Abcuro, Inc.

Abcuro develops immunotherapies to treat autoimmunity and cancer.

4

Funding Rounds

$72.3m

Money raised

Overview

Abcuro develops immunotherapies to treat autoimmunity and cancer.